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ABSTRACT 
Conflicting results have been reported on the association between restriction fragment length polymorphisms 
(RFLPs) at the vitamin D receptor O R )  gene locus (i.e., for BsmI, ApaI, and TuqI) and bone mineral density 
(BMD). We analyzed this association in a large population-based sample (n = 1782) of men and women aged 
55-80 years using a novel direct haplotyping polymerase chain reaction (PCR) test to monitor the three 
polymorphic sites simultaneously. The direct haplotyping test we developed demonstrated a larger degree of 
genetic polymorphism at the VDR gene locus than described until now. None of the individual RFLPs were 
associated with BMD at the proximal femur. By analyzing allele dose effects, we identified a VDR haplotype allele 
weakly associated with low BMD. This allele, as one representative of the group of b alleles, is different from the 
BsmI allele previously reported by other groups to be associated with low BMD. This suggests allelic heterogeneity 
at the VDR locus in relation to BMD. Our results indicate at most a small effect of the VDR genotype on BMD 
in this elderly population. Since anonymous polymorphisms were analyzed, alternative explanations for our results 
include linkage to another nearby bone-metabolism related gene. (J Bone Miner Res 19961 1A241-1248) 
INTRODUCTION 
STEOPOROS~S is characterized by low bone mineral den- 0 sity (BMD) and microarchitectural deterioration of 
bone tissue leading to increased bone fragility and suscep- 
tibility to fracture. U p  to 75% of variation in BMD has been 
suggested to be determined by genetic factors.(”’) Recent 
studies have demonstrated a genetic association between 
the vitamin D receptor (VDR) gene locus and BMD in 
Caucasian,(”” Japanese,”) and black women.(x) Other 
*PartS of this work were presented as an abstract at the XXIVth 
European Symposium on Calcified Tissues on May 27-30, 1995, in 
Aarhus, Denmark, and at the 17th annual meeting of the American 
Society for Bone and Mineral Research on September 9-13, 1995, 
in Baltimore, Maryland, U.S.A. 
studies of similar size, however, could not corroborate these 
findings.(”-”) There may be several explanations for the 
discrepancy between these studies.(I3) First, the sample size 
and consequently the statistical power of the previous stud- 
ies was limited. Second, there may have been bias, e.g., due 
to population admixture in studies, suggesting an associa- 
tion. Third, linkage disequilibrium may exist, e.g., the VDR 
gene locus itself may not be causally related to BMD but is 
linked to a neighboring bone-metabolism related gene. 
Because recombination between the VDR gene and the 
putative bone-metabolism related gene may occur at each 
meiosis, linkage disequilibrium may be found in some pop- 
ulations but not in others. Fourth, there may be allelic 
heterogeneity, i.e., the VDR gene may be implicated in 
BMD, but different gene variants are associated with BMD 
in different populations. The lack of association can then be 
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explained by the fact that a given polymorphism is not 
testing for the VDR gene variant in a particular population 
and by using less informative genetic markers. 
To address these problems, we have analyzed in a large 
population-based sample from the Rotterdam Study"" the 
association between VDR genotype and BMD of the prox- 
imal femur. The power o f  an association study can be 
increased when informative, multiallelic markers are used. 
Thc marker mostly analyzed so far in  relation to BMD is a n  
anonymous intronic restriction fragment length polymor- 
phism for BsrnI between exons 7 and 8 of the VDR gene.'-3' 
This marker discriminates only two alleles combining to 
three genotypcs. For our study, we developed a genetically 
more informative direct haplotyping PCR test to monitor 
three clustered anonymous restriction site polymorphism 
at the VDR gene locus simultaneously. Preliminary re- 
1.5.1(,) using this novel genotyping method suggested a 
considerable effect of  VDR genotype on  BMD in our pop- 
ulation. To increase further the statistical power of our 
study, we expanded the number of individuals to  include 
880 men and YO2 women. 
MATERIALS AND METHODS 
Siihjects 
The Kotterdam Study is a prospective population-based 
cohort study of determinants and prognosis of chronic dis- 
eases in the elderly.'14' Eligible for the study were all in- 
habitants aged 55 years or over of  the district of Ommoord 
in Rotterdam, The Netherlands. A total of 10,275 persons, 
o f  whom 9 I61 (89%) were living independently, were in- 
vited for the study. In the independently living population, 
the overall response rate was 77% for the home interview 
and 71% for the examination in the research centre. Writ- 
ten informcd consent was obtained from each participant. 
The Rotterdam Study has been approved by the Medical 
Ethics Committee o f  Erasmus University Medical School. 
Thc analysis o f  the association between VDR genotype and 
BMD was performed in a sample from the Rotterdam 
Study. From all 5931 independently living participants with 
bone density measurements, 1453 subjects were excluded 
according t o  the following criteria: older than 80 years, use 
of ii walking aid, known diabetes, or use of  cytostatics, 
thyroid hormone, or diuretics. From the 4478 remaining 
subjects, an age-stratified random sample of  1000 men and 
1000 women was drawn with balanced numbers (200) in 
5-year age categories. VDR genotyping data and bone den- 
sity measurements o f  880 men and 902 women were avail- 
able for analysis. 
Geriotypirig procedure 
Three anonymous polymorphic restriction enzyme recogni- 
tion sites at the 3' end o f  the VDR gene, ix., B.snz1, Apul, and 
TuqI,("~"') were assessed individually and in relation to each 
other by a direct haplotyping polymerase chain reaction 
(PCR) procedure which wc developed. The direct haplotyping 
procedure is schematically depicted in Fig. la. One hundred 
nanograms (ng) of genomic DNA was used for PCR amplifi- 
cation in a reaction mixture containing 50 mM KCI, 10  mM 
Tris-HCI (pH 8.3), 1.5 mM MgCI,, 0.2 mM dNTP, 150 ng of  
each primer, and 0.2 U of Super Taq polymerase (HT Bio- 
technology, Cambridge, U.K.). Primer VDR 1 = 5'-CAAC- 
CAA GACTACAAGTACCGCGTCAGTGA-3'; primer 
VDR4 = 5'-GCAACTCCTCATGGCTGAGGTCTC-3'.'3,J' 
The reactions were performed in a DNA thermocycler (model 
480, Perkin Elmer, Norwalk, CT, U.S.A.) and consisted of 94, 
60. and 72°C for 1 minute each, for 25 cycles. Twenty micro- 
liters (pl) of the PCR products were digested in a single tube 
with 5 U each of B.srnI,ApaI, and TuqI simultaneously, and 2.5 
pl of a 1OX buffer (containing 150 mM Tris-HCI, pH 7.5, 250 
mM NaCI, and 3.5 mM MgCI,) by subsequently incubating for 
30 minutes at 31°C followed by 30 minutes at 65°C. 
Digestion products were analyzed on a I .4% agarose gel 
run in 0.5X TBE ( I X  TBE = 8Y mM Tris, 89 mM boric 
acid, 2 mM Na2EDTA) for 250 volt hours (Vh). Separation 
patterns were documented by Polaroid photography under 
UV-illumination (302 nm). The alleles were named simi- 
larly as previously described for alleles defined by individual 
RFLPS"~.'"': in genotypes such as BAt-baT, capital letters 
denote absence and lowercase letters the presence of the 
site for the restriction enzymes BsniI (Bib), A p l  (Aia), and 
TuqI (Tit) on each of the alleles. 
To monitor complete digestion of the PCR products for 
each of the restriction enzymes used, the fragments indi- 
cated with b, aT, and t in Fig. Ib are used. The b fragment 
of 6.50 bp will only appear for those haplotypes carrying a 
BsmI recognition site (Fig. la), the t fragment o f  202 bp will 
appear only for those haplotypes carrying a T u ~ I  recogni- 
tion site, while the aT fragment will only appear for those 
haplotypes carrying an Apul recognition site but no TuqI 
recognition site. A technical problem that we initially en- 
countered in this genotyping procedure was thc occurrence 
of heteroduplex molecules (in which the + and - strands o f  
heterologous alleles are basc-pairing) which cannot be di- 
gested. By controlling the yield of the PCR amplification 
(e.g., by performing less cycles), this problem was effectively 
eliminated. To assess correspondence between the novel 
haplotyping procedure and the genotyping procedures for 
determining single restriction sites,".4' we analyzed 200 
randomly selected DNA samples by both procedures. 
Bori e min era I densi f y  m easu remen t 
BMD (in dcm') at the femoral neck and Ward's triangle The BMD data are presented as means 5 standard de- 
was determined by dual-energy X-ray absorptiometry viation (SD) or with 9574 confidence intervals (95% CI). 
(DXA; Lunar Corporation, Madison, WI, U.S.A.) as de- Rare genotypes ( n  9 10 in either men or women) wcre 
scribed Because of possihle bias due to  os- excluded from the analysis. Mean BMD was compared for 
tcoarthritis, BMD measurements of the lumbar spine were different genotypes by analysis o f  covariance (ANCOVA). 
not incIudcd."" Allele dose was defined as the number of  copies o f  a 
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particular allele in the genotype. The relation between al- 
lele dose and BMD was quantified by linear regression 
analysis for the Bsml alleles B and b and the more common 
haplotype alleles (i.e., alleles 1, 2, and 3). Since age and 
body mass index (BMI) are known determinants of bone 
density, all analyses were carried out while adjusting for age 
and BMI. 
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FIG. 1. (a) Schematic presentation 
of the direct haplotyping PCR proce- 
dure for analysis o f  the three poly- 
morphisms in the 3’ end of the VDR 
locus. UTR = untranslated region. 
(b) Gel electrophoretic separation 
pattern of restriction fragments ob- 
tained after the PCR procedure 
shown in (a) from 12 individuals with 
different VDR genotypes. The haplo- 
type notation on the left o f  the figure 
corresponds with the one shown i n  
(a) and indicates the specific restric- 
tion fragments charactcristic for each 
haplotype. b, aT, and t indicate frag- 
ments characteristic for the presence 
of an individual (b, t) or a combina- 
tion of two restriction sites (aT). in- 
var. t denotes a fragment always ob- 
served as a result of the presence of  
an invariant TuqI site in exon 9 (a). 
Numbers above the lanes refer to ge- 
notypes described in Table 4. 
Butse line 
Wor net i chamcteristic Men 
Number 880 902 
Age (years) 67.5 i 7.1 67.5 I 7.0 
BMI (kglm’) 25.5 I 2.9 26.2 1 3 . 7  
BMD (gicm’) 
Femoral neck 0.870 I 0. I30 0.803 t 0.120 
Ward’s triangle 0.720 +- 0.146 0.667 -C 0.140 
General characteristics of  the population are presented 
in Table I .  Allele and genotype frequencies for the BsmI 
restriction fragment length polymorphism (RFLP) are 
shown in Table 2. We first analyzed the association between 
BMD and VDR genotype defined by the BsniI restriction 
site polymorphism (Table 3). Although in women the BB 
genotype had a slightly higher BMD, no significant differ- 
ences were observed between genotype groups in either 
men or  women for the femoral neck nor for the Ward’s 
triangle. Allele copy number of the B or b allele was not 
significantly related to BMD. No differences in mean BMD 
levels for different ApaI and TuqI genotypes were observed 
(data not shown). 
Values arc means t SD. 
Comparison of genotyping results obtained by analysis o f  
single RFLPs and haplotypes showed no discrepancies. 
When the total population was analyzed using the direct 
haplotyping procedure, we identified five different alleles at 
the VDR gene locus coded I to 5 by decreasing frequency. 
The haplotypes combined to 12 different genotypes 
(Fig. lb), of which the frequencies are presented in Table 4. 
There were no significant differences in allele frcquencics 
between men and women. At the haplotype level there is a 
99% concordance between b and ‘1 (and B and t). N o  
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TABLE 2. BSMI ALLELE AND GENOTYPE DISTRIBUTION DISCUSSION 
Men Women All 
n (%I n (%) n (%) 
Allele* 
b 1034 (58.7) 1064 (59.0) 2098 (58.9) 
B 726 (41.3) 740 (41.0) 1466 (41.1) 
Total 1760 (100) 1804 (100) 3564 (100) 
Bb 396 (45.0) 414 (45.9) 810 (45.5) 
bb 319 (36.3) 325 (36.0) 644 (36.1) 
BB 165 (18.7) 163 (18.1) 328 (18.4) 
Total 880 (100) 902 (100) 1782 (100) 
* n  = number of chromosomes; ranking is according to 
n = number of individuals; ranking is according to frequency. 
Genotype+ 
frequency. 
significant departures from Hardy-Weinberg equilibrium 
were observed for each of the three RFLPs separately nor 
for the haplotypes. Heterozygosity was 45.5% for the BsmI 
RFLP and 56.7% for VDR alleles defined by haplotypes. 
Mean BMD values at the proximal femur of women and 
men in relation to VDR genotypes, as assessed by the direct 
haplotyping procedure, are shown in Table 5. Differences in 
mean BMD at the femoral neck and the Ward's triangle 
could be observed among VDR genotypes in men and 
women, although none reached significance. In men the 
[1,3], [2,3], and [3,3] had a BMD lower than the population 
average, whereas in women the [2,2] had a slightly higher 
BMD and the [3,3] a lower BMD. The difference in BMD 
between extreme genotypes in women was 7.3% (corre- 
sponding to 0.5 SD) of the highest BMD at the femoral 
neck and 9.7% (0.5 SD) at the Ward's triangle, while in men 
this was 4.5% (0.3 SD) and 4.7% (0.2 SD), respectively. The 
VDR haplotype allele dose effect is shown in Table 6; the 
BMD at the femoral neck decreased by 0.014 g/cmz per 
copy for allele 3 (= bAT). This allele dose effect was 
significant in the total population ( p  = 0.04), most notably 
in men ( p  = 0.06), while similar but not significant in 
women ( p  = 0.29). A similar but nonsignificant allele dose 
effect of allele 3 on BMD was observed at the Ward's 
triangle. When the analysis of allele dose effect was age- 
stratified (above and below the median age of 67 years), we 
observed for allele 3 a stronger dose effect in women 55-67 
years of age (-0.019 g/cm' [95% CI, -0.044-0.007; p = 
0.151) compared with women 67-80 years of age (-0.002 
gicm' [95% CI, -0.026-0.023; p = 0.911). For men, no 
relation of allele dose with age was found. 
Comparison of allele frequencies in the lowest and high- 
est BMD quintile of the population (cut off value for the 
lowest quintile is 0.764 g/cm2 for men and 0.698 g/cm2 for 
women, and in the highest quintile 0.987 gkm' for men and 
0.913 gicm' for women) revealed no differences for alleles 
1 and 2. Allele 3 had a higher frequency in the lowest 
quintile (13.4% for men and 13.1% for women) compared 
with the frequency in the highest quintile (10.7% for men 
and 8.9% for women; p = 0.12 for men and p < 0.01 for 
women). 
In a large ethnically homogeneous population-based 
sample, we studied the association between BMD measured 
at the proximal femur and VDR genotype. While we did not 
detect an association between individual RFLPs and BMD, 
the results suggest a weak association between BMD and 
VDR genotype as measured by direct haplotyping, with a 
similar trend in men and women. In women, the differences 
in BMD between extreme genotypes (i.e., the rare [3,3] and 
the more common [2,2] genotype) amounted up to 0.5 SD 
both at the femoral neck and at the Ward's triangle, while 
in men this difference was up to 0.3 SD. We previously 
reported larger differences in a smaller number (n = 800) 
of individuals from this population.(".lh' This imprecision 
in estimating mean BMD levels per genotype group prob- 
ably is a result of low numbers per group. In the latter case, 
the likelihood of overestimating the magnitude of an asso- 
ciation is considerable. An increase in the number of geno- 
types (because of increased genetic resolution) requires a 
concommittant increase in sample size to achieve stable and 
precise point estimates. Because the numbers of individuals 
per genotype group have now increased considerably, we 
consider the current estimates to be more reliable and 
conclude that the VDR genotype has a small effect on 
BMD in this elderly population. 
The increased genetic resolution obtained by direct hap- 
lotyping of all three polymorphic sites allowed five different 
allelic variants of the VDR gene to be discriminated, of 
which three are common. A genetically meaningful and 
efficient way to study genotype effects on BMD is to ana- 
lyze allele dose effects. When the trend among genotypes 
was analyzed with respect to allele dose, we found the 3 
allele (i.e., bAT) to be associated with low BMD. In keeping 
with these results, we found the allele 3 to be overrepre- 
sented in the lowest BMD quintile. In men, the allele dose 
effect was additive, with the homozygous [3,3] having a 
lower BMD than the heterozygous [1,3] and [2,3], which in 
turn have a BMD lower than that of individuals not carrying 
allele 3. In women, the heterozygote effect is blurred, per- 
haps by the influence of determinants of BMD other than 
VDR, e.g., estrogen status. 
When the analysis is limited to only the BsmI site, the five 
existing haplotype alleles are combined to two alleles (B 
and b). In our study, no allele dose effect of BsmI alleles 
could be observed. This is substantiated by the fact that the 
[1,1] genotype has a high mean BMD level at the femoral 
neck in women and the [3,3] the lowest mean BMD, while 
both are homozygous bb. We also observed similar trends 
both in men and women using the haplotype analysis, while 
no effect on BMD was seen with the individual polymor- 
phisms. Therefore, low genetic resolution can obscure an 
association between the BMD level and VDR genotypes in 
studies using individual restriction enzyme recognition site 
polymorphi~ms.("-'~) 
We observed frequencies of the two alleles for the BsmI 
polymorphism that are almost identical to those of other 
studies in Caucasians.('~h,"-12) Surprisingly, however, the 
particular VDR haplotype allele we found associated with 
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TABLE 3. MEAN BMD xr THE PKOXIMAL FEMUR BY BSMI GENOTYPE 
Genotype n Femoral neck* P t  Wards triangle * Pt 
Men 
BB 
Bb 
bb 
Total 
Women 
BB 
Bb 
bb 
Total 
165 0.876 (0.857-0.894) - 0.72 1 (0.70 1-0.743) - 
396 0.870 (0.858-0.881) 0.59 0.719 (0.705-0.732) 0.80 
319 0.869 (0.855-0.882) 0.56 0.720 (0.705-0.735) 0.88 
880 
I63 0.8 17 (0.796-0.832) - 0.684 (0.661-0.700) - 
414 0.798 (0.787-0.810) 0.16 0.659 (0.648-0.672) 0.09 
325 0.802 (0.790-0.815) 0.31 0.668 (0.655-0.683) 0.37 
902 
* BMD is age- and BMI-adjusted; the 95% CI is presented in brackets. 
‘Significance of differences versus BB. 
TABLF 4. VDR HAPLOTYPE A N D  GENOTYPE FRF.QULNCIES* 
Men Women All 
Code (%) (%) 
Haplotypes’. 
baT 
BAt 
bAT 
BAT 
bAt 
Total 
Genotypes* 
baT-BAt 
baT-baT 
baT-bAT 
BAt -bAT 
bAT-bAT 
BAt-BAT 
baT-BAT 
BAt-bAt 
BAt-BAt 
bAT-BAT 
baT-bAt 
b AT-bAt 
Total 
832 (47.3) 
711 (40.4) 
197 (11.1) 
15 (0.9) 
5 (0.3) 
1760 (100) 
308 (35) 
212 (24) 
1.59 (18) 
76 (8.5) 
12 (1.3) 
6 (0.7) 
3 (0.3) 
93 (11) 
6 (0.7) 
3 (0.3) 
1 (0.1) 
l(O.l) 
880 (1 00) 
869 (48.2) 
191 (10.5) 
1 0  (0.6) 
1804 (100) 
331 (37) 
223 (25) 
155 (17) 
79 (8.6) 
730 (40.5) 
4 (0.2) 
88 (9.7) 
12 (1.2) 
8 (0.9) 
2 (0.2) 
2 (0.2) 
2 (0.2) 
902 ( 100) 
- 
- 
I701 (47.7) 
1441 (40.4) 
388 (10.9) 
25 (0.7) 
9 (0.3) 
3564 ( 100) 
639 (36) 
435 (24) 
314 (18) 
183 (10) 
24 ( 1.3) 
14 (0.8) 
5 (0.3) 
155 (8.6) 
8 (0.5) 
3 (0.2) 
3 (0.2) 
I (0.1) 
1782 (100) 
* Ranking is according to frequency 
’ n = number of chromosomes. 
* n = number of individuals. 
low BMD values is different from the one reported earlier. 
According to previous studies,(’-x) the b allele was associ- 
ated with a high BMD level and the B allele with a low 
BMD level. In contrast, we find the bAT haplotype allele 
(as one representative of the group of b alleles) to be 
associated with low BMD. In this respect, it should be noted 
that a study in Scotland has recently also demonstrated an 
association of  the b allele with low BMD.(’”) Our results 
together with those of others indicate that there is either 
allelic heterogeneity at the VDR locus among different 
populations or linkage disequilibrium with another bone 
metabolism-related gene. In the latter case, the difference 
in the direction of the genetic effect (i.e., which allele is 
associated with either low or high BMD) can be explained 
by a recombination which has occurred between the VDR 
gene and the putative bone metabolism-related gene in our 
study population. Alternatively, in the case of allelic heter- 
ogeneity, it is expected that differences in biological effect 
and direction of the genetic effect might be accompanied by 
differences in haplotype distributions among different pop- 
ulations. Arguing against allelic heterogeneity in this re- 
spect is the fact that haplotype frequencies in a Japanese 
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TABLL 5 . MEAN BMD A I  THF PROXIMAL F ~ M U R  RY VDR HAP~OTYPE GFNOIYPFS* 
Genotype n Femoral neck P’ Ward’s triangle P.t 
159 
212 
308 
93 
76 
12 
20 
880 
155 
223 
33 1 
88 
79 
12 
14 
902 
0.876 (0.857-0.894) 
0.877 (0.860-0.893) 
0.871 (0.858-0.88s) 
0.855 (0.830-0.880) 
0.858 (0.83 1-0.886) 
0.837 (0.769-0.906) 
not given 
0.8 13 (0.795-0.832) 
0.805 (0.789-0.820) 
0.800 (0.787-0.81 3) 
0.797 (0.771-0.823) 
not given 
0.803 (0.779-0.828) 
0.754 (0.688-0.821) 
- 
0.94 
0.72 
0.19 
0.31 
0.30 
- 
0.47 
0.25 
0.52 
0.3 1 
0.10 
0.722 (0.700-0.743) 
0.728 (0.709-0.746) 
0.720 (0.705-0.736) 
0.708 (0.676-0.739) 
0.688 (0.610-0.766) 
not given 
0.708 (0.680-0.736) 
0.679 (0.659-0.699) 
0.672 (0.655-0.688) 
0.660 (0.646-0.674) 
0.664 (0.636-0.692) 
not given 
0.670 (0.643-0.696) 
0.613 (0.541-0.685) 
~~ 
- 
0.6’) 
0.9 I 
0.44 
0.46 
0.4 1 
- 
0.56 
0.12 
0.57 
0.37 
0.08 
* Genotypes are ranked according to mean BMD at the femoral neck; rare genotypes have n 5 10 in either mcn o r  womcn; BMD i \  
+ Significance o f  differences versus [2,2]. 
age- and BMI-adjusted; the Y5% CI is presented in brackets. 
TABLE 6. REGRESSION F BMD AT THE PROXIMAL FEMUR ON VDR ALLELE DOSE* 
VDR allele Men P Women P All P 
Femoral neck 
1 0.004 (-0.007-O.OlS) 0.49 -0.001 (-0.012-0.01 1) 0.87 0.001 (-0.OO7-0.OO9) 0.87 
2 0.003 (-0.008-0.014) 0.62 0.005 (-0.006-0.016) 0.41 0.005 (-0.004-O.OI4) 0.27 
3 -0.018 (-0.036-0.0003) 0.06 -0.010 (-0.027-0.007) 0.29 -0.014 (-0.027--0.001) 0.04 
Ward’s triangle 
1 0.006 (-0.007-0.019) 0.37 0.0001 (-0.015-0.012) 0.99 0.002 (-O.OO7-0.01 I) 0.04 
2 0.001 (-0.012-0.013) 0.98 0.003 (-0.009-0.01s) 0.64 0.003 (-0.007-0.012) 0.58 
3 -0.016 (-0.036-0.005) 0.13 -0.008 (-0.027-0.007) 0.44 -0.012 (-0.026-0.002) 0.  I0 
~~ ~~ ~ ~- 
* Presented is the regression coefficicnt: the increment or decrement in BMD per VDR allele copy (in brackets is the 95% 0)  
population‘*” and an Australian population,(”) although 
inferred and not determined directly, are very different, but 
they show the same VDR allele being associated with high 
BMD. In addition, haplotype frequencies in the Australian 
population and our population are similar, but different 
VDR alleles are associated with low BMD. The direction of 
a genetic effect, however, can also be influenced by gene- 
environment interactions. Allelic heterogeneity could thus 
be explained as different alleles having the same effect in 
different populations due to differences in environment. 
Environmental influences such as Calcium (Ca) intake are 
known to differ widely between populations(22) and have 
been shown to contribute to the genetic effect of VDR 
genotype on BMD‘” and on rates of bone loss.(2” How- 
ever, in a preliminary analysis of dietary Ca intake in rela- 
tion to BMD and VDR genotype in our population, which 
has a relatively high Ca intake (mean is 1139 and 1093 
mgiday in men and women, respectively), we observed that 
the small effect of dietary Ca intake on BMD was not 
strongly VDR genotype-dependent (data not shown). An 
analysis of the relationship between the VDR genotype, Ca 
intake, BMD, and rates of  loss is now under way. 
In the absence of knowledge on functional sequence 
variations in the VDR gene in linkage with the three poly- 
morphisms described so far, neither allelic heterogeneity 
nor linkage disequilibrium with another bone metabolism- 
related gene can be excluded as an explanation for the 
different direction and magnitude of the genetic effect o f  
VDR genotype on BMD between different studies. In  this 
respect, a more comprehensive analysis of sequence varia- 
tion in functionally relevant parts of the VDR locus but also 
in its direct chromosomal vicinity will help to make a dis- 
tinction. It should be noted that other examples of one 
allele having different genetic effects are known to occur. 
For example, in the case of the association between ApoE 
alleles and early onset Alzheimers disease (EOAD), some 
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studies showed a protective effect of the E2 allele while 
others demonstrated an increased risk of EOAD for ApoE2 
carriers.(24’ Also in this case, possible explanations for the 
opposite genetic effect are along the lines described above. 
Finally, differences between VDR genotypes in BMD 
levels could reflect differences in peak bone mass as ob- 
tained in young adulthood and/or be due to differences in 
age-related bone loss. Preliminary follow-up data from our 
population (mean follow-up time 2.4 years) indicate that a 
high BMD is not due to a lower rate of bone loss (data not 
shown). This at least suggests that subjects with VDR ge- 
notypes characterized by a low BMD level are apparently 
not fast bone losers. In this respect, it should be noted that 
in an elderly population the VDR genotype effect on BMD 
can be attenuated by other determinants of BMD such as 
life-style factors, including diet and mobility. A role of VDR 
genotype in determining peak bone mass can therefore not 
be excluded. 
In conclusion, we found a weak association between 
VDR genotype and BMD. The increased genetic resolution 
allowed us to identify an allele associated with low BMD, 
which is different from the one found previously by other 
groups. Neither allelic heterogeneity of the VDR gene nor 
linkage disequilibrium of the VDR locus with another bone 
metabolism-related gene can be excluded to explain the 
differences in direction of the genetic effect between our 
study and other studies. Based on current evidence, it ap- 
pears likely that the differences in bone mass between the 
different genotypes are obtained early in life rather than 
due to age-related bone loss. Studies of the association of 
VDR genotype with peak bone mass in younger individuals 
will help to clarify this issue. 
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